Skip to main content
PMC home page
Tobacco Control logoLink to Tobacco Control
. 2004 Mar;13(1):52–56. doi: 10.1136/tc.2003.004093

Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use

J Haas 1, C Kaplan 1, D Barenboim 1, P Jacob 1, N Benowitz 1
PMCID: PMC1747823  PMID: 14985597

Abstract

Objectives: To assess potential infant exposure to bupropion and its active metabolites in breast milk such as would occur during treatment to prevent post-partum relapse to tobacco use, and to compare the concentrations of bupropion in urine and saliva with plasma and breast milk.

Design and setting: Cohort study, outpatient clinical research centre.

Subjects: Ten healthy post-partum volunteers who agreed to take bupropion for seven days, pump and discard their breast milk, and have samples of breast milk, plasma, saliva, and urine analysed.

Intervention: Bupropion 150 mg a day for three days and then 300 mg a day for four days.

Main outcome measures: Concentrations of bupropion and its active metabolites (hydroxybupropion, erythrohydrobupropion, threohydrobupropion) in breast milk, plasma, saliva, and urine. Determination of average infant exposure.

Results: The calculated average dosage of bupropion in breast milk was 6.75 µg/kg/day. Therefore, the average infant exposure is 0.14 % of the standard adult dose of bupropion, corrected for the difference in body weight. Considering the sum of bupropion and its active metabolites, the average infant exposure is expected to be 2% of the standard maternal dose on a molar basis. The concentration of bupropion and its active metabolites in breast milk was not associated with age, body mass index, use of oral contraceptive pills, age of infant, or the frequency of breast feeding at the time the study was initiated. The coefficient of determination (r2) between the concentration of bupropion in breast milk and in urine was 0.77 (p < 0.01).

Conclusions: Bupropion and its active metabolites are present in the breast milk of lactating women. The concentrations of bupropion in breast milk and urine were highly correlated. These results indicate that the daily dose of bupropion and metabolites that would be delivered to an infant of a woman taking a therapeutic dose of bupropion is small. These results suggest that the effectiveness of bupropion to prevent post-partum relapse to tobacco use should be evaluated without excluding women who plan to breast feed.

Full Text

The Full Text of this article is available as a PDF (173.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascher J. A., Cole J. O., Colin J. N., Feighner J. P., Ferris R. M., Fibiger H. C., Golden R. N., Martin P., Potter W. Z., Richelson E. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry. 1995 Sep;56(9):395–401. [PubMed] [Google Scholar]
  2. Baab Susan W., Peindl Kathleen S., Piontek Catherine M., Wisner Katherine L. Serum bupropion levels in 2 breastfeeding mother-infant pairs. J Clin Psychiatry. 2002 Oct;63(10):910–911. doi: 10.4088/jcp.v63n1008. [DOI] [PubMed] [Google Scholar]
  3. Brenner H., Mielck A. The role of childbirth in smoking cessation. Prev Med. 1993 Mar;22(2):225–236. doi: 10.1006/pmed.1993.1019. [DOI] [PubMed] [Google Scholar]
  4. Briggs G. G., Samson J. H., Ambrose P. J., Schroeder D. H. Excretion of bupropion in breast milk. Ann Pharmacother. 1993 Apr;27(4):431–433. doi: 10.1177/106002809302700406. [DOI] [PubMed] [Google Scholar]
  5. Britton G. A. A review of women and tobacco: have we come such a long way? J Obstet Gynecol Neonatal Nurs. 1998 May-Jun;27(3):241–249. doi: 10.1111/j.1552-6909.1998.tb02645.x. [DOI] [PubMed] [Google Scholar]
  6. Carmichael S. L., Ahluwalia I. B. Correlates of postpartum smoking relapse. Results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Am J Prev Med. 2000 Oct;19(3):193–196. doi: 10.1016/s0749-3797(00)00198-7. [DOI] [PubMed] [Google Scholar]
  7. Dolan-Mullen P., Ramírez G., Groff J. Y. A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol. 1994 Nov;171(5):1328–1334. doi: 10.1016/0002-9378(94)90156-2. [DOI] [PubMed] [Google Scholar]
  8. Ebrahim S. H., Merritt R. K., Floyd R. L. Smoking and women's health: opportunities to reduce the burden of smoking during pregnancy. CMAJ. 2000 Aug 8;163(3):288–289. [PMC free article] [PubMed] [Google Scholar]
  9. Ershoff D. H., Mullen P. D., Quinn V. P. A randomized trial of a serialized self-help smoking cessation program for pregnant women in an HMO. Am J Public Health. 1989 Feb;79(2):182–187. doi: 10.2105/ajph.79.2.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fingerhut L. A., Kleinman J. C., Kendrick J. S. Smoking before, during, and after pregnancy. Am J Public Health. 1990 May;80(5):541–544. doi: 10.2105/ajph.80.5.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gardiner Sharon J., Kirkpatrick Carl M. J., Begg Evan J., Zhang Mei, Moore M. Peter, Saville Dorothy J. Transfer of metformin into human milk. Clin Pharmacol Ther. 2003 Jan;73(1):71–77. doi: 10.1067/mcp.2003.9. [DOI] [PubMed] [Google Scholar]
  12. Gonzales David, Bjornson Wendy, Durcan Michael J., White Jonathan D., Johnston J. Andrew, Buist A. Sonia, Sachs David P. L., Rigotti Nancy A., Niaura Raymond, Hays J. Taylor. Effects of gender on relapse prevention in smokers treated with bupropion SR. Am J Prev Med. 2002 May;22(4):234–239. doi: 10.1016/s0749-3797(02)00419-1. [DOI] [PubMed] [Google Scholar]
  13. Hale T. W., Kristensen J. H., Hackett L. P., Kohan R., Ilett K. F. Transfer of metformin into human milk. Diabetologia. 2002 Sep 25;45(11):1509–1514. doi: 10.1007/s00125-002-0939-x. [DOI] [PubMed] [Google Scholar]
  14. Hays J. T., Hurt R. D., Rigotti N. A., Niaura R., Gonzales D., Durcan M. J., Sachs D. P., Wolter T. D., Buist A. S., Johnston J. A. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med. 2001 Sep 18;135(6):423–433. doi: 10.7326/0003-4819-135-6-200109180-00011. [DOI] [PubMed] [Google Scholar]
  15. Hsyu P. H., Singh A., Giargiari T. D., Dunn J. A., Ascher J. A., Johnston J. A. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers. J Clin Pharmacol. 1997 Aug;37(8):737–743. doi: 10.1002/j.1552-4604.1997.tb04361.x. [DOI] [PubMed] [Google Scholar]
  16. Hurt R. D., Sachs D. P., Glover E. D., Offord K. P., Johnston J. A., Dale L. C., Khayrallah M. A., Schroeder D. R., Glover P. N., Sullivan C. R. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997 Oct 23;337(17):1195–1202. doi: 10.1056/NEJM199710233371703. [DOI] [PubMed] [Google Scholar]
  17. Johnston J. A., Fiedler-Kelly J., Glover E. D., Sachs D. P., Grasela T. H., DeVeaugh-Geiss J. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Nicotine Tob Res. 2001 May;3(2):131–140. doi: 10.1080/14622200110042852. [DOI] [PubMed] [Google Scholar]
  18. Jorenby D. E., Leischow S. J., Nides M. A., Rennard S. I., Johnston J. A., Hughes A. R., Smith S. S., Muramoto M. L., Daughton D. M., Doan K. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685–691. doi: 10.1056/NEJM199903043400903. [DOI] [PubMed] [Google Scholar]
  19. Lando H. A., Valanis B. G., Lichtenstein E., Curry S. J., McBride C. M., Pirie P. L., Grothaus L. C. Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches. Am J Manag Care. 2001 Jul;7(7):685–693. [PubMed] [Google Scholar]
  20. Leung Gabriel M., Ho Lai-Ming, Lam Tai-Hing. Maternal, paternal and environmental tobacco smoking and breast feeding. Paediatr Perinat Epidemiol. 2002 Jul;16(3):236–245. doi: 10.1046/j.1365-3016.2002.00426.x. [DOI] [PubMed] [Google Scholar]
  21. Lillington L. M. AHCPR smoking cessation guideline goals and impact: examples from the nursing field. Tob Control. 1997;6 (Suppl 1):S39–S43. [PubMed] [Google Scholar]
  22. McBride C. M., Curry S. J., Lando H. A., Pirie P. L., Grothaus L. C., Nelson J. C. Prevention of relapse in women who quit smoking during pregnancy. Am J Public Health. 1999 May;89(5):706–711. doi: 10.2105/ajph.89.5.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McBride C. M., Pirie P. L., Curry S. J. Postpartum relapse to smoking: a prospective study. Health Educ Res. 1992 Sep;7(3):381–390. doi: 10.1093/her/7.3.381. [DOI] [PubMed] [Google Scholar]
  24. McBride C. M., Pirie P. L. Postpartum smoking relapse. Addict Behav. 1990;15(2):165–168. doi: 10.1016/0306-4603(90)90020-x. [DOI] [PubMed] [Google Scholar]
  25. Mullen P. D., Quinn V. P., Ershoff D. H. Maintenance of nonsmoking postpartum by women who stopped smoking during pregnancy. Am J Public Health. 1990 Aug;80(8):992–994. doi: 10.2105/ajph.80.8.992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Quinn V. P., Mullen P. D., Ershoff D. H. Women who stop smoking spontaneously prior to prenatal care and predictors of relapse before delivery. Addict Behav. 1991;16(1-2):29–40. doi: 10.1016/0306-4603(91)90037-i. [DOI] [PubMed] [Google Scholar]
  27. Ratner P. A., Johnson J. L., Bottorff J. L., Dahinten S., Hall W. Twelve-month follow-up of a smoking relapse prevention intervention for postpartum women. Addict Behav. 2000 Jan-Feb;25(1):81–92. doi: 10.1016/s0306-4603(99)00033-7. [DOI] [PubMed] [Google Scholar]
  28. Stowe Zachary N., Hostetter Amy L., Owens Michael J., Ritchie James C., Sternberg Kevan, Cohen Lee S., Nemeroff Charles B. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry. 2003 Jan;64(1):73–80. doi: 10.4088/jcp.v64n0114. [DOI] [PubMed] [Google Scholar]
  29. Wakefield M., Jones W. Effects of a smoking cessation program for pregnant women and their partners attending a public hospital antenatal clinic. Aust N Z J Public Health. 1998;22(3 Suppl):313–320. doi: 10.1111/j.1467-842x.1998.tb01383.x. [DOI] [PubMed] [Google Scholar]
  30. Wall M. A., Severson H. H., Andrews J. A., Lichtenstein E., Zoref L. Pediatric office-based smoking intervention: impact on maternal smoking and relapse. Pediatrics. 1995 Oct;96(4 Pt 1):622–628. [PubMed] [Google Scholar]
  31. Windsor R. A., Cutter G., Morris J., Reese Y., Manzella B., Bartlett E. E., Samuelson C., Spanos D. The effectiveness of smoking cessation methods for smokers in public health maternity clinics: a randomized trial. Am J Public Health. 1985 Dec;75(12):1389–1392. doi: 10.2105/ajph.75.12.1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Windsor R. A., Lowe J. B., Perkins L. L., Smith-Yoder D., Artz L., Crawford M., Amburgy K., Boyd N. R., Jr Health education for pregnant smokers: its behavioral impact and cost benefit. Am J Public Health. 1993 Feb;83(2):201–206. doi: 10.2105/ajph.83.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wisner K. L., Perel J. M., Findling R. L. Antidepressant treatment during breast-feeding. Am J Psychiatry. 1996 Sep;153(9):1132–1137. doi: 10.1176/ajp.153.9.1132. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES